theatlantic.com/health/archive…

This paper is almost done, we just need to do this last experiment. Famous last words... 9 months and counting. Whats your number? Do share.

Ohio State University (The James Cancer Center) The James at Ohio State is accepting application for Adult BMT-CT clinical fellowship👇

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease frontiersin.org/article/10.338… Yay! its in print. Our first manuscript supported by our first R01. Ok, now back to grant submission.

Long-Term Trends in the Age of Principal Investigators Supported for the First Time on NIH R01-Equivalent Awards nexus.od.nih.gov/all/2021/11/18… 44 is the new 40?!

Thrilled to share that I received a Research Scholar Grant from the American Cancer Society to study the role of PRMT5 in GVHD. Grateful to ACS Research for supporting junior PIs. Many thanks to fabulous collaborators robert baiocchi Stephen D. Nimer, MD So many exciting experiments ahead

molbiolcell.org/doi/10.1091/mb…

Fantastic time at #ASH22. Met old friends and made new ones. All fired up to get back to the bench.

Outstanding meeting #Tandem23. Fun science and the coolest scientists! #sumithira_vasu #Byersdoc_BMT #MMaversMDPhD

The place to be #Miami Party

What a see-saw of a month!!! On one hand, manuscript gets accepted for publication, while on the other- grant based on the manuscript gets the dreaded ND. Forgive me while I go stick my head in the sand for a bit :(

So proud of Katiri who successfully defended her dissertation today! Dr.Snyder in the house!!!

A fantastic commencement ceremony, hooding my first PhD student Dr.Snyder and celebrating with my undergraduate student Simran Surana! A perfect Sunday despite the sweltering temperatures!

And with that Pelotonia 2024 is under the belt. What a great day for a ride! Thanks for the fantastic company! Maria Mihaylova

Happening soon - see us at noon! So excited to welcome Dr.Ivan Maillard to OSU! Can’t wait to hear the coolest stuff happening with Notch signaling!!! Ohio State Hematology

Way to go Ashley Rosko!

Hannah Choe presenting her oral abstract at #ASH24. Expert GVHD doc bringing important treatments to patients!!

Excited to share our latest research at the 2024 ASH Annual Meeting! Join me as I present the ongoing trial using Mocravimod, an innovative S1PR modulator with dual effect —> aiming to augment GvL while decreasing the risk of GvHD. This global Phase III trial is exploring its

We are 3 for 3 on approvals to proceed from the FDA on INDs for 2025 👏👏👏 amazing work by the Cell Therapy Lab team at The James and our fantastic colleagues. Can’t wait to bring these novel therapies to patients!! Marcos de Lima Sumithira Vasu Dr Lynn O'Donnell

We are incredibly excited to have Kimryn Rathmell join the The James as our CEO! We look forward to advancing her vision for improving care and therapeutic options for all patients with blood cancers! #itsagreatdaytobeaBuckeye